Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial.
Berwanger O, de Barros E Silva PGM, Dall Orto FTC, de Andrade PB, de Castro Bienert IR, Bosso CE, Mangione J, Polanczyk CA, Sousa A, Kalil R, de Moura Santos L, Sposito AC, Rech RL, Sousa ACS, Baldissera F, Nascimento BR, de Andrade Jesuíno I, Santucci EV, Damiani LP, Laranjeira LN, Borges de Oliveira JA, Giraldez RR, Cavalcanti AB, Pereira SB, Mattos LA, Armaganijan LV, Guimarães HP, Sousa JE, Alexander JH, Granger CB, Lopes RD. Berwanger O, et al. Among authors: baldissera f. Am Heart J. 2018 Apr;198:129-134. doi: 10.1016/j.ahj.2017.12.018. Epub 2018 Jan 8. Am Heart J. 2018. PMID: 29653634 Clinical Trial.
Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
Berwanger O, Santucci EV, de Barros E Silva PGM, Jesuíno IA, Damiani LP, Barbosa LM, Santos RHN, Laranjeira LN, Egydio FM, Borges de Oliveira JA, Dall Orto FTC, Beraldo de Andrade P, Bienert IRC, Bosso CE, Mangione JA, Polanczyk CA, Sousa AGMR, Kalil RAK, Santos LM, Sposito AC, Rech RL, Sousa ACS, Baldissera F, Nascimento BR, Giraldez RRCV, Cavalcanti AB, Pereira SB, Mattos LA, Armaganijan LV, Guimarães HP, Sousa JEMR, Alexander JH, Granger CB, Lopes RD; SECURE-PCI Investigators. Berwanger O, et al. Among authors: baldissera f. JAMA. 2018 Apr 3;319(13):1331-1340. doi: 10.1001/jama.2018.2444. JAMA. 2018. PMID: 29525821 Free PMC article. Clinical Trial.
Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial.
Fonseca HAR, Furtado RHM, Zimerman A, Lemos PA, Franken M, Monfardini F, Pedrosa RP, Patriota RLS, Passos LCS, Dall'Orto FTC, Hoffmann Filho CR, Nascimento BR, Baldissera FA, Pereira CAC, Caramori PRA, de Andrade PB, Esteves C, Salim EF, da Silva JH, Pedro IC, Silva MCR, de Pedri EH, Carioca ACRD, de Piano LPA, Albuquerque CSN, Moia DDF, Momesso RGRAP, Machado FP, Damiani LP, Soares RVP, Schettino GP, Rizzo LV, Nicolau JC, Berwanger O. Fonseca HAR, et al. Among authors: baldissera fa. Eur Heart J. 2022 Nov 1;43(41):4378-4388. doi: 10.1093/eurheartj/ehac472. Eur Heart J. 2022. PMID: 36030400 Clinical Trial.
In-Hospital influenza vaccination to prevent cardiorespiratory events in the first 45 days after acute coronary syndrome: A prespecified analysis of the VIP-ACS trial.
Fonseca HAR, Zimerman A, Monfardini F, Guimarães HP, Pedrosa RP, Patriota RLS, Couto Patriota TLG, Passos LCS, Dall'Orto FTC, Hoffmann Filho CR, Nascimento BR, Baldissera FA, Pereira CAC, Caramori PRA, Andrade PB, Okoshi MP, Polanczyk CA, Silveira FS, Villacorta AS, Nicolau JC, Rizzo LV, Berwanger O; VIP-ACS team. Fonseca HAR, et al. Among authors: baldissera fa. Vaccine. 2024 Jan 25;42(3):496-504. doi: 10.1016/j.vaccine.2023.12.074. Epub 2023 Dec 27. Vaccine. 2024. PMID: 38154990
Randomized Noninferiority Trial of Radiation Exposure During Coronary Angiography: the Transradial and Transfemoral Approach by EXPERienced Operators in Daily rouTine (EXPERT) Trial.
de Oliveira Cardoso C, de Moraes CV, Teixeira JV, Cardoso CR, Baldissera F, de Mattos EI, Siqueira MJ, Fischer L, Sebben JC, Santos Silva B, Broetto G, Antônio Mascia Gottschall C, Sarmento-Leite R. de Oliveira Cardoso C, et al. Among authors: baldissera f. Tex Heart Inst J. 2023 Mar 1;50(2):e227930. doi: 10.14503/THIJ-22-7930. Tex Heart Inst J. 2023. PMID: 36944120 Free PMC article. Clinical Trial.
Zinc and Manganese Imbalances in BALB/c Mice Experimentally Infected with Leishmania (Leishmania) amazonensis.
Sobotyk C, Baldissera FG, Rodrigues Junior LC, Romão PRT, de Oliveira JS, Dornelles GL, de Andrade CM, Maciel RM, Danesi CC, de Padua Ferreira RV, Bellini MH, de Avila Botton S, Vogel FSF, Sangioni LA. Sobotyk C, et al. Among authors: baldissera fg. Acta Parasitol. 2023 Jun;68(2):447-452. doi: 10.1007/s11686-023-00666-1. Epub 2023 Mar 8. Acta Parasitol. 2023. PMID: 36884141
Imidazolium salts as an alternative for anti-Leishmania drugs: Oxidative and immunomodulatory activities.
Baldissera FG, Fazolo T, da Silva MB, de Santana Filho PC, da Silva VD, Rivillo Perez DM, Klitzke JS, de Oliveira Soares EG, Rodrigues Júnior LC, Peres A, Dallegrave E, Navegantes-Lima KC, Monteiro MC, Schrekker HS, Torres Romão PR. Baldissera FG, et al. Front Immunol. 2023 Jan 17;13:1096312. doi: 10.3389/fimmu.2022.1096312. eCollection 2022. Front Immunol. 2023. PMID: 36733394 Free PMC article.
How motoneurones control velocity of tension development.
Baldissera F, Campadelli P, Cavallari P, Piccinelli L, Tesio L. Baldissera F, et al. J Physiol. 2020 Mar;598(5):1109-1110. doi: 10.1113/JP279066. Epub 2020 Feb 3. J Physiol. 2020. PMID: 32010982 Free article. No abstract available.
Leishmanicidal and antichemotactic activities of icetexanes from Salvia uliginosa Benth.
Cezarotto CS, Dorneles A, Baldissera FG, da Silva MB, Markoski MM, Júnior LCR, Peres A, Fazolo T, Bordignon SAL, Apel MA, Romão PRT, von Poser GL. Cezarotto CS, et al. Among authors: baldissera fg. Phytomedicine. 2019 May;58:152748. doi: 10.1016/j.phymed.2018.11.009. Epub 2018 Nov 12. Phytomedicine. 2019. PMID: 31005722
134 results